The growth of the viral vector manufacturing market can be attributed to several factors such as increased incidences of infectious diseases, increased utilization of viral vectors to develop gene therapies and vaccines, and increased support & investments in gene therapies and vaccines. However, challenges associated with viral vector production & manufacturing, the presence of stringent regulatory policies, and risks associated with viral vectors may hamper the growth of the vector industry over the forecast period.
Market Industry Reports (MIR) has published a new report titled “Viral Vector Manufacturing Market– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global viral vector manufacturing market accounted for over US$ 350 million in 2019. It is anticipated to grow at a CAGR of 15.2% from 2020 to 2030.
Get sample copy of “Viral Vector Manufacturing Market” at:
Some of the prominent players in the Viral Vector Manufacturing Market include:
• Brammer Bio
• Merck KGaA
• Oxford BioMedica
• CGT Catapult
• Creative Biogene
• andThermo Fisher Scientific Inc.
• among others.
The utilization of viral gene transfer vectors has expanded due to the acceptance of treatments, the introduction of late-stage clinical trials to treat genetic defects & various types of cancer, and the need for vaccinations to prevent infectious diseases. With growing interest around viral vectors and their widespread adoption by biopharmaceutical industries, there is an imperative on engineering safer & more efficacious vectors and cost-effective production platforms for industrialization. Additionally, adeno-associated virus vectors are among the most widely utilized in vivo gene therapy virus vectors since they can transduce non-dividing and dividing cells, further contributing to long-term and stable transgene expression. This trend will have a positive effect on the overall growth of the sector.
Due to the increasing incidences of various life-threatening diseases, such as diabetes, heart diseases, HIV, cancer, and hemophilia A, the development of therapies involving viral vectors is in high demand. Scientists utilize viral vectors to establish curative medicines for cancers including prostate cancer, skin melanoma, lung & bronchial cancer, and others. This is because viral vectors are a promising method for vaccine production and gene therapy. Thus, the rising prevalence of chronic diseases during the forecast period will contribute to the growing global demand for viral vectors at a CAGR of over 15 percent.
The Viral Vector Manufacturing Market is segmented on the basis of Product, Modality, Cancer Type, End-Users and region.
Adenoviral Vectors, Retroviral Vectors, and Adeno-associated Viral Vectors
By Disease Indication:
Cancer, Genetic Disorders, and Infectious Disease
Vaccinology andGene Therapy
Research Institutionsand Pharmaceutical & Biopharmaceutical Companies
Have any query? Inquiry about report at:
Table of Contents
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecasted Years – 2020 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
Buy this report @
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Phone: + 91 8956767535